The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy
出版年份 2018 全文链接
标题
The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy
作者
关键词
-
出版物
JOURNAL OF MEDICAL VIROLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-11-01
DOI
10.1002/jmv.25352
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection
- (2017) Hidenori Toyoda et al. HEPATOLOGY
- Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
- (2017) Kazuaki Chayama et al. JOURNAL OF GASTROENTEROLOGY
- The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy
- (2017) Yuko Nagaoki et al. PLoS One
- Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection
- (2016) Joji Toyota et al. JOURNAL OF GASTROENTEROLOGY
- The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study
- (2016) Hiromitsu Kumada et al. JOURNAL OF GASTROENTEROLOGY
- Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study
- (2016) Yuko Nagaoki et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma
- (2016) Tatsuya Minami et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment
- (2016) Harrys A. Torres et al. JOURNAL OF HEPATOLOGY
- High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
- (2016) Helder Cardoso et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection
- (2016) Masahiro Kobayashi et al. JOURNAL OF MEDICAL VIROLOGY
- Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hepatitis C virus-infected patients
- (2015) Kazuaki Chayama et al. HEPATOLOGY
- Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis
- (2015) Hiromitsu Kumada et al. HEPATOLOGY
- Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
- (2015) Masashi Mizokami et al. LANCET INFECTIOUS DISEASES
- Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection
- (2014) Hiromitsu Kumada et al. HEPATOLOGY
- Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
- (2014) Masao Omata et al. JOURNAL OF VIRAL HEPATITIS
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
- (2011) Shuichiro Shiina et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma
- (2010) A. K. Singal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
- (2010) Hiroaki Hagihara et al. International Journal of Clinical Oncology
- Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
- (2010) Ying-Chun Shen et al. JOURNAL OF HEPATOLOGY
- Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b
- (2010) Tomokazu Kawaoka et al. JOURNAL OF HEPATOLOGY
- Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: A meta-analysis of randomized controlled trials
- (2009) Chuan-Hai Zhang et al. INTERNATIONAL JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started